Lacritec is an Australian-developed, patented formulation designed to provide continuous relief from dry eye discomfort. Unlike topical eye drops, Lacritec works from the inside out, targeting the root causes of dry eye by supporting healthy tear production and reducing inflammation.

Key Features

• Advanced Omega Blend: Combines Omega-3 fatty acids (EPA and DHA) from fish oil, Alpha-Linolenic Acid (ALA) from flaxseed oil, and Gamma-Linolenic Acid (GLA) from borage oil to support tear film stability and reduce ocular inflammation.
• Systemic Relief: By addressing internal inflammation, Lacritec enhances tear production and quality, offering sustained relief from dry eye symptoms.
• Clinically Observed Benefits: In a follow-up study of 209 patients, significant symptom improvement and a reduction in eye drop usage were observed after 8 weeks of Lacritec supplementation.

Ideal For

• Individuals with chronic dry eye syndrome or meibomian gland dysfunction 
• Contact lens wearers who get contact lens dryness
• Frequent travelers or those exposed to air-conditioned environments
• Individuals experiencing digital eye strain or post-laser eye surgery recovery

Dosage

• Initial Phase: Take 3 capsules daily with meals for the first 6 weeks.
• Maintenance Phase: Reduce to 2 capsules daily with meals.

Adjust dosage based on individual response and consult with a healthcare professional as needed.

Active Ingredients (per capsule)

• Concentrated Omega-3 Triglycerides (Fish Oil): 332 mg
  • Eicosapentaenoic Acid (EPA): 134 mg
  • Docosahexaenoic Acid (DHA): 66.8 mg
• Flaxseed Oil: 334 mg
  • Oleic Acid: 58.5 mg
  • Linoleic Acid: 58.5 mg
  • Alpha-Linolenic Acid (ALA): 192 mg
• Borage Oil: 434 mg
  • Gamma-Linolenic Acid (GLA): 95.5 mg

Lacritec offers a comprehensive, systemic approach to managing dry eye symptoms, making it a valuable addition to your eye care regimen.